Comparative study of hepatitis C virus antibody between hemodialysis and continuous ambulatory peritoneal dialysis patients.

H. Y. Lee, D. H. Kang, C. S. Park, K. Y. Kim, S. W. Kang, H. S. Kim, K. H. Choi, S. K. Ha, D. S. Han

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

We have done cross sectional and prospective studies to determine the prevalence and the clinical significance of antibodies to the hepatitis C virus (Anti-HCV) in 54 hemodialysis (HD) patients and 227 continuous ambulatory peritoneal dialysis (CAPD) patients. Fifteen patients (27.8%) were anti-HCV (+) among the HD group, and twelve patients (5.3%) were anti-HCV (+) among the CAPD group. In the HD group, the positivity of anti-HCV correlated with the duration of HD, but there was no significant correlation with the history of transfusion, the amount of transfusion and abnormal alanine aminotransferase (ALT). At the follow-up study in 164 cases (HD 50 cases, CAPD 114 cases) after 6 months, one of 14 anti-HCV (+) CAPD patients was converted to anti-HCV (-) and two of 35 anti-HCV (-) HD patients were converted to anti-HCV (+). In conclusion, the prevalence of anti-HCV was significantly higher in HD patients compared to CAPD patients, and the positivity for anti-HCV in HD patients correlated with the duration of HD. A regular follow-up of anti-HCV and isolation of anti-HCV (+) HD patients with a separate machine may be needed to prevent the transmission of the hepatitis C virus during hemodialysis.

Original languageEnglish
Pages (from-to)371-380
Number of pages10
JournalYonsei medical journal
Volume34
Issue number4
DOIs
Publication statusPublished - 1993 Dec

Fingerprint

Hepatitis C Antibodies
Continuous Ambulatory Peritoneal Dialysis
Renal Dialysis
Alanine Transaminase
Hepacivirus
Cross-Sectional Studies
History
Prospective Studies

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Lee, H. Y. ; Kang, D. H. ; Park, C. S. ; Kim, K. Y. ; Kang, S. W. ; Kim, H. S. ; Choi, K. H. ; Ha, S. K. ; Han, D. S. / Comparative study of hepatitis C virus antibody between hemodialysis and continuous ambulatory peritoneal dialysis patients. In: Yonsei medical journal. 1993 ; Vol. 34, No. 4. pp. 371-380.
@article{8f3ccc431c044842bfd52eb7d49df9bd,
title = "Comparative study of hepatitis C virus antibody between hemodialysis and continuous ambulatory peritoneal dialysis patients.",
abstract = "We have done cross sectional and prospective studies to determine the prevalence and the clinical significance of antibodies to the hepatitis C virus (Anti-HCV) in 54 hemodialysis (HD) patients and 227 continuous ambulatory peritoneal dialysis (CAPD) patients. Fifteen patients (27.8{\%}) were anti-HCV (+) among the HD group, and twelve patients (5.3{\%}) were anti-HCV (+) among the CAPD group. In the HD group, the positivity of anti-HCV correlated with the duration of HD, but there was no significant correlation with the history of transfusion, the amount of transfusion and abnormal alanine aminotransferase (ALT). At the follow-up study in 164 cases (HD 50 cases, CAPD 114 cases) after 6 months, one of 14 anti-HCV (+) CAPD patients was converted to anti-HCV (-) and two of 35 anti-HCV (-) HD patients were converted to anti-HCV (+). In conclusion, the prevalence of anti-HCV was significantly higher in HD patients compared to CAPD patients, and the positivity for anti-HCV in HD patients correlated with the duration of HD. A regular follow-up of anti-HCV and isolation of anti-HCV (+) HD patients with a separate machine may be needed to prevent the transmission of the hepatitis C virus during hemodialysis.",
author = "Lee, {H. Y.} and Kang, {D. H.} and Park, {C. S.} and Kim, {K. Y.} and Kang, {S. W.} and Kim, {H. S.} and Choi, {K. H.} and Ha, {S. K.} and Han, {D. S.}",
year = "1993",
month = "12",
doi = "10.3349/ymj.1993.34.4.371",
language = "English",
volume = "34",
pages = "371--380",
journal = "Yonsei Medical Journal",
issn = "0513-5796",
publisher = "Yonsei University College of Medicine",
number = "4",

}

Comparative study of hepatitis C virus antibody between hemodialysis and continuous ambulatory peritoneal dialysis patients. / Lee, H. Y.; Kang, D. H.; Park, C. S.; Kim, K. Y.; Kang, S. W.; Kim, H. S.; Choi, K. H.; Ha, S. K.; Han, D. S.

In: Yonsei medical journal, Vol. 34, No. 4, 12.1993, p. 371-380.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Comparative study of hepatitis C virus antibody between hemodialysis and continuous ambulatory peritoneal dialysis patients.

AU - Lee, H. Y.

AU - Kang, D. H.

AU - Park, C. S.

AU - Kim, K. Y.

AU - Kang, S. W.

AU - Kim, H. S.

AU - Choi, K. H.

AU - Ha, S. K.

AU - Han, D. S.

PY - 1993/12

Y1 - 1993/12

N2 - We have done cross sectional and prospective studies to determine the prevalence and the clinical significance of antibodies to the hepatitis C virus (Anti-HCV) in 54 hemodialysis (HD) patients and 227 continuous ambulatory peritoneal dialysis (CAPD) patients. Fifteen patients (27.8%) were anti-HCV (+) among the HD group, and twelve patients (5.3%) were anti-HCV (+) among the CAPD group. In the HD group, the positivity of anti-HCV correlated with the duration of HD, but there was no significant correlation with the history of transfusion, the amount of transfusion and abnormal alanine aminotransferase (ALT). At the follow-up study in 164 cases (HD 50 cases, CAPD 114 cases) after 6 months, one of 14 anti-HCV (+) CAPD patients was converted to anti-HCV (-) and two of 35 anti-HCV (-) HD patients were converted to anti-HCV (+). In conclusion, the prevalence of anti-HCV was significantly higher in HD patients compared to CAPD patients, and the positivity for anti-HCV in HD patients correlated with the duration of HD. A regular follow-up of anti-HCV and isolation of anti-HCV (+) HD patients with a separate machine may be needed to prevent the transmission of the hepatitis C virus during hemodialysis.

AB - We have done cross sectional and prospective studies to determine the prevalence and the clinical significance of antibodies to the hepatitis C virus (Anti-HCV) in 54 hemodialysis (HD) patients and 227 continuous ambulatory peritoneal dialysis (CAPD) patients. Fifteen patients (27.8%) were anti-HCV (+) among the HD group, and twelve patients (5.3%) were anti-HCV (+) among the CAPD group. In the HD group, the positivity of anti-HCV correlated with the duration of HD, but there was no significant correlation with the history of transfusion, the amount of transfusion and abnormal alanine aminotransferase (ALT). At the follow-up study in 164 cases (HD 50 cases, CAPD 114 cases) after 6 months, one of 14 anti-HCV (+) CAPD patients was converted to anti-HCV (-) and two of 35 anti-HCV (-) HD patients were converted to anti-HCV (+). In conclusion, the prevalence of anti-HCV was significantly higher in HD patients compared to CAPD patients, and the positivity for anti-HCV in HD patients correlated with the duration of HD. A regular follow-up of anti-HCV and isolation of anti-HCV (+) HD patients with a separate machine may be needed to prevent the transmission of the hepatitis C virus during hemodialysis.

UR - http://www.scopus.com/inward/record.url?scp=0027733383&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027733383&partnerID=8YFLogxK

U2 - 10.3349/ymj.1993.34.4.371

DO - 10.3349/ymj.1993.34.4.371

M3 - Article

C2 - 7510444

AN - SCOPUS:0027733383

VL - 34

SP - 371

EP - 380

JO - Yonsei Medical Journal

JF - Yonsei Medical Journal

SN - 0513-5796

IS - 4

ER -